HuagongsheHuagongshe Chemistry Print Report · For research reference only
Tert-butyl 4-(hydroxymethyl)piperidine-1-carboxylate → 4-(4-Bromo-2,6-difluoroanilino)-7-(1-(tert-butoxycarbonyl)piperidin-4-ylmethoxy)-6-methoxyquinazoline
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Tert-butyl 4-(hydroxymethyl)piperidine-1-carboxylate | HCID 2764081 | — |
| Reactant | 4-(4-Bromo-2,6-difluoroanilino)-7-hydroxy-6-methoxyquinazoline | HCID 135493544 | — |
| Product | 4-(4-Bromo-2,6-difluoroanilino)-7-(1-(tert-butoxycarbonyl)piperidin-4-ylmethoxy)-6-methoxyquinazoline | HCID 10973897 | 41% |
Reaction Steps
Using an analogous procedure to that described in the preparation of the starting material in Example 8, 4-(4-bromo-2,6-difluoroanilino)-7-hydroxy-6-methoxyquinazoline (1 g, 2.62 mmol) was reacted with 1-(tert-butoxycarbonyl)-4-hydroxymethylpiperidine (845 mg, 3.93 mmol), (prepared as described for the starting material in Example 1), to give 4-(4-bromo-2,6-difluoroanilino)-7-(1-(tert-butoxycarbonyl)piperidin-4-ylmethoxy)-6-methoxyquinazoline (620 mg, 41%).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08642608B2 |
| Source dataset | uspto-grants-2014_02 |
| ORD ID | ord-7405efded057413aafc63145250572dd |
| Source note | uspto-grants-2014_02 |